Epstein-Barr virus, latitude and multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 3, 2013, Pages 362-365

  Disanto, Giulio ^a,b   Pakpoor, Julia ^a,b   Morahan, Julia M ^a,b   Hall, Carolina ^d   Meier, Ute C ^c   Giovannoni, Gavin ^c   Ramagopalan, Sreeram V ^a,b,c,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Epstein Barr virus; interaction; latitude; multiple sclerosis; vitamin D

Indexed keywords

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; IMMUNE RESPONSE; LATITUDE; MULTIPLE SCLEROSIS; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SYSTEMATIC REVIEW;

EID: 84874346355     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512451942     Document Type: Article

References (10)

1. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G.. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010 ; 9: 727-739
2. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A.. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010 ; 67: 824-830
3. Ascherio A, Munger KL.. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007 ; 61: 288-299
4. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV.. An updated meta- analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. 2010 ;: 5
5. Ascherio A, Munger KL.. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007 ; 61: 504-513
6. Webb AR, Kline L, Holick MF.. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988 ; 67: 373-378
7. de Ory F, Guisasola ME, Sanz JC, Garcia-Bermejo I.. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections. Clin Vaccine Immunol. 2011 ; 18: 444-448
8. Beard JA, Bearden A, Striker R.. Vitamin D and the anti-viral state. J Clin Virol. 2011 ; 50: 194-200
9. Lucas RM, Ponsonby AL, Dear K, et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology. 2011 ; 77: 371-379
10. Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A.. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler. 2011 ; 17: 1185-1193